Streetbeat News

Analyst Ratings

ACER

Roth Capital analyst Jonathan Aschoff has downgraded Acer Therapeutics (NASDAQ:ACER) from Buy to Neutral, while maintaining a $1.5 price target.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 3:05 pm

AMRK

DA Davidson analyst Tom Forte maintains a Buy rating on A-Mark Precious Metals (NASDAQ:AMRK) and raises the price target from $57 to $66.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 3:04 pm

GMS

Stephens & Co. analyst Trey Grooms maintains an Overweight rating on GMS (NYSE:GMS) and raises the price target from $85 to $87.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 3:02 pm

FCX

A significant bearish stance has been taken on Freeport-McMoRan (NYSE:FCX) by a large investor or institution, as indicated by unusual options trading activity. The sentiment among these big-money traders is 80% bearish and 20% bullish. The whales have been targeting a price range from $36.0 to $45.0 for Freeport-McMoRan over the last 3 months. The price of FCX is currently up 4.36% at $41.65, and RSI indicators suggest the stock may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:01 pm

CHK

In the last quarter, Chesapeake Energy (NASDAQ:CHK) received 6 bullish and 4 indifferent ratings from analysts. The company's average 12-month price target is $94.7, a decrease of 2.57% from the previous average of $97.20.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:00 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) has received 4 bullish ratings from analysts in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the company is $56.5, a decrease of 0.88% from the previous average of $57.00.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:00 pm

VRNA

Verona Pharma (NASDAQ:VRNA) has received predominantly bullish ratings from analysts in the last quarter, with 5 bullish and 1 somewhat bullish ratings. The average 12-month price target for the stock, according to 6 analysts, is $32.17, marking a 14.89% increase over the past month.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:00 pm

CHS

In the last quarter, Chico's FAS (NYSE:CHS) received one bullish rating and five indifferent ratings from analysts. The company's average 12-month price target is $6.21, representing a 32.86% decrease from the previous average price target of $9.25.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:00 pm

DVN

Over the past 3 months, 15 analysts have published their opinion on Devon Energy (NYSE:DVN) stock. The average price target is $62.53, implying an upside from the current price of $52.5047. This represents a 4.53% decrease from the previous average price target of $65.50.

Portfolio Pulse from Benzinga Insights

September 01, 2023 | 3:00 pm

AAPL

AMZN

GOOGL

MSFT

NVDA

QQQ

SPY

Market Clubhouse's Morning Memo discusses trade strategies for SPY, QQQ, AAPL, AMZN, GOOGL, MSFT, and NVDA. The analysis is based on a proprietary formula that considers price, volume, and options flow. The memo provides potential bullish and bearish scenarios for each stock, with specific price targets.

Portfolio Pulse from RIPS

September 01, 2023 | 3:00 pm